Intron a and Hypertriglyceridaemia - a phase IV clinical study of FDA data

Summary:

Hypertriglyceridaemia is reported as a side effect among people who take Intron a (interferon alfa-2b), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Rebetol, and have Malignant melanoma.

The phase IV clinical study analyzes which people have Hypertriglyceridaemia when taking Intron a. It is created by eHealthMe based on reports of 9,303 people who have side effects when taking Intron a from the FDA, and is updated regularly.

What is Intron a?

Intron a has active ingredients of interferon alfa-2b. eHealthMe is studying from 9,320 Intron a users. Check the latest studies of Intron a.

What is Hypertriglyceridaemia?

Hypertriglyceridaemia (excess of triglycerides in the blood) is found to be associated with 754 drugs and 763 conditions by eHealthMe. Check the latest studies of Hypertriglyceridaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

9,303 people reported to have side effects when taking Intron a.
Among them, 43 people (0.46%) have Hypertriglyceridaemia.

Could Intron a cause Hypertriglyceridaemia?

Among these 43 people:

How long have people been on Intron a when they have Hypertriglyceridaemia? *

What is the gender of people who have Hypertriglyceridaemia when taking Intron a? *

female: 46.88 %
male: 53.12 %

What is the age of people who have Hypertriglyceridaemia when taking Intron a? *

What are other drugs people take besides Intron a? *

What are other side effects people have besides Hypertriglyceridaemia? *

High Blood Cholesterol: 16 people, 37.21%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 4 people, 9.30%
Weight Decreased: 4 people, 9.30%
Haemoglobin Decreased: 4 people, 9.30%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 9.30%
Fever: 3 people, 6.98%
Thrombocytopenia (decrease of platelets in blood): 3 people, 6.98%
Liver Function Tests Nos Abnormal: 3 people, 6.98%
White Blood Cell Count Decreased: 2 people, 4.65%
Muscle Aches (muscle pain): 2 people, 4.65%

What are the existing conditions these people have? *

Malignant Melanoma (skin cancer rises from melancytes): 2 people, 4.65%
Radiation Pneumonitis (inflammation of lung due to radiation): 1 person, 2.33%
Hepatitis C: 1 person, 2.33%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Intron a and have Hypertriglyceridaemia?

- Check whether Hypertriglyceridaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intron a:

Intron a (9,320 reports)

Browse all side effects of Intron a:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (754 drugs)

Browse all the conditions that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (763 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on interferon alfa-2b (the active ingredients of Intron a) and Intron a (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.